Your browser doesn't support javascript.
loading
Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade.
Daugan, Marie V; Revel, Margot; Thouenon, Romane; Dragon-Durey, Marie-Agnès; Robe-Rybkine, Tania; Torset, Carine; Merle, Nicolas S; Noé, Rémi; Verkarre, Virginie; Oudard, Stephane Marie; Mejean, Arnaud; Validire, Pierre; Cathelineau, Xavier; Sanchez-Salas, Rafael; Pickering, Mathew C; Cremer, Isabelle; Mansuet-Lupo, Audrey; Alifano, Marco; Sautès-Fridman, Catherine; Damotte, Diane; Fridman, Wolf H; Roumenina, Lubka T.
Afiliação
  • Daugan MV; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
  • Revel M; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
  • Thouenon R; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
  • Dragon-Durey MA; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
  • Robe-Rybkine T; Department of Biologic Immunology, Hôpital Européen Georges-Pompidou, Assistance Publique Hopitaux de Paris, Paris, France.
  • Torset C; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
  • Merle NS; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
  • Noé R; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
  • Verkarre V; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
  • Oudard SM; Université de Paris, Paris, France.
  • Mejean A; Department of Pathology, Hôpital Européen Georges-Pompidou, Assistance Publique Hopitaux de Paris, Paris, France.
  • Validire P; Université de Paris, Paris, France.
  • Cathelineau X; Department of Oncology, Hôpital Européen Georges-Pompidou, Assistance Publique Hopitaux de Paris, Paris, France.
  • Sanchez-Salas R; Université de Paris, Paris, France.
  • Pickering MC; Department of Urology, Hôpital Européen Georges-Pompidou, Assistance Publique Hopitaux de Paris, Paris, France.
  • Cremer I; Department of Pathology, Institut Mutualiste Montsouris, Paris, France.
  • Mansuet-Lupo A; Université de Paris, Paris, France.
  • Alifano M; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Sautès-Fridman C; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Damotte D; Centre for Complement and Inflammation Research, Imperial College, London, United Kingdom.
  • Fridman WH; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
  • Roumenina LT; Team Inflammation, Complement and Cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
Cancer Immunol Res ; 9(8): 909-925, 2021 08.
Article em En | MEDLINE | ID: mdl-34039652
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator H do Complemento / Ativação do Complemento Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator H do Complemento / Ativação do Complemento Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França